Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Henk J. Adriaansen"'
Publikováno v:
The Journal of Applied Laboratory Medicine. 6:1067-1071
Autor:
Harry J. de Koning, Jeanine E. Roeters van Lennep, Dirkjan Kuijpers, Richard L. Braam, Jan Willem C. Gratama, Paul R. M. van Dijkman, Matthijs Oudkerk, Rozemarijn Vliegenthart, Pim van der Harst, Henk J Adriaansen, Marleen Vonder, Rykel van Bruggen, Carlijn M. van der Aalst, Sabine J A M Denissen
Publikováno v:
European Heart Journal-Cardiovascular Imaging, 21(11), 1216-1224. Oxford University Press
European Heart Journal-Cardiovascular Imaging, 21(11), 1216-1224. OXFORD UNIV PRESS
European Heart Journal Cardiovascular Imaging, 21(11), 1216-1224. Oxford University Press
European Heart Journal-Cardiovascular Imaging, 21(11), 1216-1224. OXFORD UNIV PRESS
European Heart Journal Cardiovascular Imaging, 21(11), 1216-1224. Oxford University Press
Aims Screening for a high cardiovascular disease (CVD) risk followed by preventive treatment can potentially reduce coronary heart disease-related morbidity and mortality. ROBINSCA (Risk Or Benefit IN Screening for CArdiovascular disease) is a popula
Autor:
Harry J. de Koning, Carlijn M. van der Aalst, Jan Willem C. Gratama, Paul R. M. van Dijkman, Rozemarijn Vliegenthart, Jeanine E. Roeters van Lennep, Sabine J A M Denissen, Dirkjan Kuijpers, Matthijs Oudkerk, Pim van der Harst, Richard L. Braam, Marleen Vonder, Henk J Adriaansen
Publikováno v:
European Journal of Preventive Cardiology, 28(10), 1155-1159. SAGE Publications Ltd
European Journal of Preventive Cardiology, 281(10), 1155-1159. SAGE PUBLICATIONS LTD
European journal of preventive cardiology, 28(10):2047487320932263, 1155-1159. SAGE Publications Inc.
European Journal of Preventive Cardiology, 281(10), 1155-1159. SAGE PUBLICATIONS LTD
European journal of preventive cardiology, 28(10):2047487320932263, 1155-1159. SAGE Publications Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbdf74c80e821e6d2eb25ba8694799b7
https://doi.org/10.1177/2047487320932263
https://doi.org/10.1177/2047487320932263
Autor:
Henk J Adriaansen, Martijn W. H. J. Demmers, Huibert Storm, Johannes J M L Hoffmann, Christiaan L Slim, Jurgen A. Kooren, Gabriella Lakos, Brigitte A Wevers
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 57:1988-1998
Background Alinity hq (Abbott) is a new high-throughput hematology analyzer that exclusively employs optical principles for detecting and enumerating blood cells. It reports 29 parameters, including a six-part white blood cell (WBC) differential. The
Autor:
Martijn W. H. J. Demmers, Marijke Niens, Henk J Adriaansen, Johannes J M L Hoffmann, Hester J. van der Zaag-Loonen, Gerrie van der Haar
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 56:450-456
Introduction Functional iron deficiency parameters predict iron-restricted erythropoiesis more precisely than ferritin. Ferritin and erythropoiesis can be affected by inflammation and hormonal alterations. We hypothesize that the association between
Autor:
P. R. M. Van Dijkman, C. Van der Aalst, Dirkjan Kuijpers, J-W C. Gratema, P. van der Harst, Richard L. Braam, M. Oudkerk, Marleen Vonder, Henk J Adriaansen, Sabine J A M Denissen, Rozemarijn Vliegenthart, R. Van Bruggen, H.J. de Koning, J.E. Roeters van Lennep, Robinsca
Publikováno v:
European Heart Journal. 41
Aims Screening for a high cardiovascular disease (CVD) risk followed by preventive treatment can potentially reduce coronary heart disease (CHD)-related morbidity and mortality. ROBINSCA (Risk Or Benefit IN Screening for CArdiovascular disease) is a
Autor:
P. van der Harst, Marleen Vonder, Matthijs Oudkerk, Dirkjan Kuijpers, Richard L. Braam, J. Dijkstra, Sabine J A M Denissen, H.J. de Koning, C. Van der Aalst, R. Van Bruggen, Jan Willem C. Gratama, Henk J Adriaansen, F. W. Beltman, P. R. M. Van Dijkman
Publikováno v:
European Heart Journal. 40
Introduction The ROBINSCA (Risk Or Benefit IN Screening for CArdiovascular disease) trial is a large-scale population-based randomized controlled screening trial with the aim to investigate whether screening for a high risk of cardiovascular disease
Autor:
F. J. M. Van Der Meer, Marieke J. H. A. Kruip, Joseph S. Biedermann, Henk J. Adriaansen, A. M. H. P. Van Den Besselaar, F. W. G. Leebeek
Publikováno v:
Thrombosis and Haemostasis, 117(4), 820-821. Georg Thieme Verlag
Thrombosis and Haemostasis, 117(4), 820-821
Thrombosis and Haemostasis, 117(4), 820-821
Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cced987503aedebef709696b066e904
https://hdl.handle.net/1887/114563
https://hdl.handle.net/1887/114563
Autor:
Henk J. Adriaansen, A. M. H. P. Van Den Besselaar, Felix J. M. van der Meer, Frank W.G. Leebeek, Joseph S. Biedermann, Marieke J. H. A. Kruip
Publikováno v:
Thrombosis and Haemostasis, 116(4), 679-686
Thrombosis and Haemostasis, 116(4), 679-686. Georg Thieme Verlag
Thrombosis and Haemostasis, 116(4), 679-686. Georg Thieme Verlag
SummaryPatients receiving vitamin K–antagonists are monitored by regular assessment of the International Normalized Ratio (INR). There are two popular methods for therapeutic control of anticoagulation in patient groups: 1) Time in Therapeutic Rang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c577816369c5ce1f1b615111648fe2b7
http://hdl.handle.net/1887/112564
http://hdl.handle.net/1887/112564
Autor:
Jan Lindemans, Edward Sanders, Sandra G. Heil, J Maurits M Pekelharing, Ton Rammeloo, Rebecca M R Heiner-Fokkema, Robert de Jonge, Anneke C. Muller Kobold, Merel van Wijnen, Maurits C.F.J. de Rotte, Henk J Adriaansen, Paul H Trienekens
Publikováno v:
Annals of Clinical Biochemistry, 49, 184-189. SAGE Publications Ltd
Annals of Clinical Biochemistry, 49(2), 184-189. SAGE Publications Inc.
Annals of Clinical Biochemistry, 49(2), 184-189. SAGE Publications Inc.
Background Vitamin B12 deficiency occurs frequently, especially among the elderly. However, screening for vitamin B12 deficiency is hampered by poor sensitivity of the existing total vitamin B12 assay. Methylmalonic acid (MMA) is considered as the mo